Home > Newsletters > Drug Industry Daily > Keep Exchange of Science-Based Information on Off-Label Uses Open, Drugmakers Tell FDA
Drug Industry Daily
April 4, 2012 | Vol. 11 No. 67
Keep Exchange of Science-Based Information on Off-Label Uses Open, Drugmakers Tell FDA
Biopharma companies should be allowed to provide factual, non-misleading information about their products’ uses in an open, scientific dialogue whether uses are off-label or not, drugmakers are telling the FDA.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.